The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Differential exoprotease activities confer tumor-specific serum peptidome patterns
Open accessAbstract
Recent studies have established distinctive serum polypeptide patterns through mass spectrometry (MS) that reportedly correlate with clinically relevant outcomes. Wider acceptance of these signatures as valid biomarkers for disease may follow sequence characterization of the components and elucidation of the mechanisms by which they are generated. Using a highly optimized peptide extraction and matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF) MS-based approach, we now show that a limited subset of serum peptides (a signature) provides accurate class discrimination between patients with 3 types of solid tumors and controls without cancer. Targeted sequence identification of 61 signature peptides revealed that they fall into several tight clusters and that most are generated by exopeptidase activities that confer cancer type-specific differences superimposed on the proteolytic events of the ex vivo coagulation and complement degradation pathways. This small but robust set of marker peptides then enabled highly accurate class prediction for an external validation set of prostate cancer samples. In sum, this study provides a direct link between peptide marker profiles of disease and differential protease activity, and the patterns we describe may have clinical utility as surrogate markers for detection and classification of cancer. Our findings also have important implications for future peptide biomarker discovery efforts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Etzioni, R., Urban, N., Ramsey, S., McIntosh, M., Schwartz, S., Reid, B., Radich, J., Anderson, G., & Hartwell, L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1041 · Cited by 1,155
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R., Shapiro, L., Arap, W., & Ruoslahti, E. I. (2000) · PubMed · Cited by 966
Zhang, Z., Bast, R. C., Yu, Y., Li, J., Sokoll, L. J., Rai, A. J., Rosenzweig, J. M., Cameron, B., Wang, Y. Y., Meng, X.-Y., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0746 · Cited by 934
Li, J., Zhang, Z., Rosenzweig, J., Wang, Y. Y., & Chan, D. W. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.8.1296 · Cited by 893
Characterization of the Low Molecular Weight Human Serum Proteome
Tirumalai, R. S., Chan, K. C., Prieto, D. A., Issaq, H. J., Conrads, T. P., & Veenstra, T. D. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300031-mcp200 · Cited by 860
Molecular mechanisms of glioma invasiveness: the role of proteases
Rao, J. S. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1121 · Cited by 847
Toward a Human Blood Serum Proteome
Adkins, J. N., Varnum, S. M., Auberry, K. J., Moore, R. J., Angell, N. H., Smith, R. D., Springer, D. L., & Pounds, J. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200066-mcp200 · Cited by 793
Emerging molecular markers of cancer
Sidransky, D. (2002) · Nature Reviews Cancer · doi:10.1038/nrc755 · Cited by 662
Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool
Diamandis, E. P. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r400007-mcp200 · Cited by 631
Adam, B.-L., Qu, Y., Davis, J. W., Ward, M. D., Clements, M. A., Cazares, L. H., Semmes, O. J., Schellhammer, P. F., Yasui, Y., Feng, Z., et al. (2002) · PubMed · Cited by 612
Sahu, A., & Lambris, J. D. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1800103.x · Cited by 525
Bias as a threat to the validity of cancer molecular-marker research
Ransohoff, D. F. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1550 · Cited by 487
Hormonal, cellular, and molecular control of prostatic development
Marker, P. C., Donjacour, A. A., Dahiya, R., & Cunha, G. R. (2003) · Developmental Biology · doi:10.1016/s0012-1606(02)00031-3 · Cited by 469
Villanueva, J., Philip, J., Entenberg, D., Chaparro, C. A., Tanwar, M. K., Holland, E. C., & Tempst, P. (2004) · Analytical Chemistry · doi:10.1021/ac0352171 · Cited by 449
Self-citationThe structural basis of the multiple forms of human complement component C4
Tertia Belt, K., Carroll, M. C., & Porter, R. R. (1984) · Cell · doi:10.1016/0092-8674(84)90040-0 · Cited by 420
Clinical Utility of Biochemical Markers of Bone Remodeling
Watts, N. B. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.8.1359 · Cited by 336
The Human Plasma Proteome: History, Character, and Diagnostic Prospects
Anderson, N. L., & Anderson, N. G. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.a300001-mcp200 · Cited by 284
Griffith, E. C., Su, Z., Niwayama, S., Ramsay, C. A., Chang, Y.-H., & Liu, J. O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15183 · Cited by 262
Molecular portraits and the family tree of cancer
Chung, C. H., Bernard, P. S., & Perou, C. M. (2002) · Nature Genetics · doi:10.1038/ng1038 · Cited by 262
High-resolution serum proteomic features for ovarian cancer detection.
Conrads, T. P., Fusaro, V. A., Ross, S., Johann, D., Rajapakse, V, Hitt, B. A., Steinberg, S. M., Kohn, E. C., Fishman, D. A., Whitely, G., et al. (2004) · Endocrine-related cancer · doi:10.1677/erc.0.0110163 · Cited by 260
Thrombin, Thrombomodulin and TAFI in the Molecular Link Between Coagulation and Fibrinolysis
Nesheim, M., Wang, W., Boffa, M., Nagashima, M., Morser, J., & Bajzar, L. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657557 · Cited by 258
Kapp, E. A., Schütz, F., Reid, G. E., Eddes, J. S., Moritz, R. L., O'Hair, R. A. J., Speed, T. P., & Simpson, R. J. (2003) · Analytical Chemistry · doi:10.1021/ac034616t · Cited by 255
The inter-α-inhibitor family: from structure to regulation
SALIER, J.-P., ROUET, P., RAGUENEZ, G., & DAVEAU, M. (1996) · Biochemical Journal · doi:10.1042/bj3150001 · Cited by 253
Processing of Serum Proteins Underlies the Mass Spectral Fingerprinting of Myocardial Infarction
Marshall, J., Kupchak, P., Zhu, W., Yantha, J., Vrees, T., Furesz, S., Jacks, K., Smith, C., Kireeva, I., Zhang, R., et al. (2003) · Journal of Proteome Research · doi:10.1021/pr030003l · Cited by 229
Koomen, J. M., Li, D., Xiao, L.-C., Liu, T. C., Coombes, K. R., Abbruzzese, J., & Kobayashi, R. (2005) · Journal of Proteome Research · doi:10.1021/pr050046x · Cited by 223
Correcting Common Errors in Identifying Cancer-Specific Serum Peptide Signatures
Villanueva, J., Philip, J., Chaparro, C. A., Li, Y., Toledo-Crow, R., DeNoyer, L., Fleisher, M., Robbins, R. J., & Tempst, P. (2005) · Journal of Proteome Research · doi:10.1021/pr050034b · Cited by 215
Self-citationJuly, L. V., Akbari, M., Zellweger, T., Jones, E. C., Goldenberg, S. L., & Gleave, M. E. (2002) · The Prostate · doi:10.1002/pros.10047 · Cited by 213
Blood: A Textbook of Hematology.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-504_5 · Cited by 195
Composition of the peptide fraction in human blood plasma: database of circulating human peptides
Richter, R., Schulz-Knappe, P., Schrader, M., Ständker, L., Jürgens, M., Tammen, H., & Forssmann, W.-G. (1999) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(99)00012-2 · Cited by 193
Essler, M., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251687998 · Cited by 193
Changes in the Protein Expression of Yeast as a Function of Carbon Source
Gao, J., Opiteck, G. J., Friedrichs, M. S., Dongre, A. R., & Hefta, S. A. (2003) · Journal of Proteome Research · doi:10.1021/pr034038x · Cited by 186
Check, E. (2004) · Nature · doi:10.1038/429496a · Cited by 168
Kinetics of Serum Tumor Marker Concentrations and Usefulness in Clinical Monitoring
Bidart, J.-M., Thuillier, F., Augereau, C., Chalas, J., Daver, A., Jacob, N., Labrousse, F., & Voitot, H. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.10.1695 · Cited by 159
Serum proteomics profiling—a young technology begins to mature
Coombes, K. R., Morris, J. S., Hu, J., Edmonson, S. R., & Baggerly, K. A. (2005) · Nature Biotechnology · doi:10.1038/nbt0305-291 · Cited by 158
Human Aminopeptidases: A Review of the Literature
Sanderink, G., Artur, Y., & Siest, G. (1988) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1988.26.12.795 · Cited by 148
Novel Role of Prostate-Specific Membrane Antigen in Suppressing Prostate Cancer Invasiveness
Ghosh, A., Wang, X., Klein, E. A., & Heston, W. D. W. (2005) · Cancer Research · doi:10.1158/0008-5472.727.65.3 · Cited by 132
Gene Expression Profiling of Lymphoid Malignancies
Staudt, L. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103941 · Cited by 116
Ornstein, D. K., Rayford, W., Fusaro, V. A., Conrads, T. P., Ross, S., Hitt, B. A., WIGGINS, W. W., Veenstra, T. D., Liotta, L. A., & Petricoin, E. F. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000139572.88463.39 · Cited by 112
Clusterin (SGP‐2, ApoJ) expression is downregulated in low‐ and high‐grade human prostate cancer
Scaltriti, M., Brausi, M. A., Amorosi, A., Caporali, A., D’Arca, D., Astancolle, S., Corti, A., & Bettuzzi, S. (2003) · International Journal of Cancer · doi:10.1002/ijc.11496 · Cited by 109
Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
Kehlen, A., Lendeckel, U., Dralle, H., Langner, J., & Hoang‐Vu, C. (2003) · PubMed · Cited by 105
In Vitro Biomarker Discovery for Atherosclerosis by Proteomics
Fach, E. M., Garulacan, L. A., Gao, J., Xiao, Q., Storm, S. M., Dubaquié, Y., Hefta, S. A., & Opiteck, G. J. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400160-mcp200 · Cited by 92
Identification of Gastric Cancer Patients by Serum Protein Profiling
Ebert, M. P., Meuer, J., Wiemer, J. C., Schulz, H., Reymond, M. A., Traugott, U., Malfertheiner, P., & Röcken, C. (2004) · Journal of Proteome Research · doi:10.1021/pr049865s · Cited by 90
Place of Pattern in Proteomic Biomarker Discovery
Gillette, M. A., Mani, D. R., & Carr, S. A. (2005) · Journal of Proteome Research · doi:10.1021/pr0500962 · Cited by 86
ADAMs, a disintegrin and metalloproteinases, mediate shedding of oxytocinase
Ito, N., Nomura, S., Iwase, A., Ito, T., Kikkawa, F., Tsujimoto, M., Ishiura, S., & Mizutani, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.183 · Cited by 85
Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid.
van Hensbergen, Y., Broxterman, H. J., Hanemaaijer, R., Jorna, A. S., van Lent, N., Verheul, H. M. W., Pinedo, H. M., & Hoekman, K. (2002) · PubMed · Cited by 82
cDNA and deduced amino acid sequence of human PK‐120, a plasma kallikrein‐sensitive glycoprotein
Nishimura, H., Kakizaki, I., Muta, T., Sasaki, N., Pu, P. X., Yamashita, T., & Nagasawa, S. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01364-7 · Cited by 80
Aminopeptidase Activities in Breast Cancer Tissue
Martinez, J. M., Prieto, I., Ramírez-Expósito, M. J., Cueva, C., Alba, F., & Ramírez, M. R. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.10.1797 · Cited by 77
Bergen, H. R., Vasmatzis, G., Cliby, W. A., Johnson, K. L., Oberg, A. L., & Muddiman, D. C. (2004) · Disease Markers · doi:10.1155/2004/797204 · Cited by 71
Extracellular proteolysis and cancer: meeting summary and future directions.
Matrisian, L. M., Sledge, G. W., & Mohla, S. (2003) · PubMed · Cited by 67
Petrovic, N., Bhagwat, S. V., Ratzan, W. J., Ostrowski, M. C., & Shapiro, L. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308071200 · Cited by 66
Hugosson, J., Aus, G., Lilja, H. G., et al. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000061183.43229.2e · Cited by 62
High Expression of Methionine Aminopeptidase 2 in Human Colorectal Adenocarcinomas
Selvakumar, P., Lakshmikuttyamma, A., Kanthan, R., Kanthan, S. C., Dimmock, J. R., & Sharma, R. K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0218 · Cited by 53
Strategies for Developing Biomarkers of Heart Failure
Jortani, S. A., Prabhu, S. D., & Valdes, R. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.027557 · Cited by 50
3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2
Sheppard, G. S., Wang, J., Kawai, M., BaMaung, N. Y., Craig, R. A., Erickson, S. A., Lynch, L., Patel, J. R., Yang, F., Searle, X. B., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.031 · Cited by 40
Leroy Hood expounds the principles, practice and future of systems biology
Carney, S. L. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02710-7 · Cited by 40
Kojima, K., Mihara, R., Sakai, T., Togari, A., Matsui, T., SHINPO, K., Fujita, K., Fukasawa, K. M., Harada, M., & Nagatsu, T. (1987) · Biochemical Medicine and Metabolic Biology · doi:10.1016/0885-4505(87)90007-7 · Cited by 35
Isolation and identification of hydroxyproline analogues of bradykinin in human urine
Kato, H., Matsumura, Y., & Maeda, H. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80427-7 · Cited by 28
Suganuma, T., Ino, K., Shibata, K., Nomura, S., Kajiyama, H., Kikkawa, F., Tsuruoka, N., & Mizutani, S. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700072 · Cited by 26
Role of Aminopeptidases in the Blood Pressure Regulation
Mitsui, T., Nomura, S., Itakura, A., et al. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.768 · Cited by 25
Peptide Metabolism and the Control of Body Fluid Homeostasis
Silveira, P. F., Gil, J., Casis, L., & Irazusta, J. (2004) · Current Medicinal Chemistry - Cardiovascular & Hematological Agents · doi:10.2174/1568016043356264 · Cited by 16
O’Malley, P., Sangster, S. M., Abdelmagid, S. A., Bearne, S. L., & Too, C. K. L. (2005) · Biochemical Journal · doi:10.1042/bj20050025 · Cited by 14
Cited by
Shilov, I. V., Seymour, S. L., Patel, A. A., Loboda, A., Tang, W. H., Keating, S. P., Hunter, C. L., Nuwaysir, L. M., & Schaeffer, D. A. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t600050-mcp200 · Cited by 1,298
Label-free cell separation and sorting in microfluidic systems
Gossett, D. R., Weaver, W. M., Mach, A. J., Hur, S. C., Tse, H. T. K., Lee, W., Amini, H., & Di Carlo, D. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3721-9 · Cited by 930
Henry, N. L., & Hayes, D. F. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.01.010 · Cited by 849
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
Kulasingam, V., & Diamandis, E. P. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1187 · Cited by 771
Human body fluid proteome analysis
Hu, S., Loo, J. A., & Wong, D. T. (2006) · PROTEOMICS · doi:10.1002/pmic.200600284 · Cited by 533
Metadata
- Authors
- Villanueva, J.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-12-08
- Volume
- 116
- Issue
- 1
- Pages
- 271-284
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2157492758
- Cited by
- 741
- References
- 66
- FWCI
- 24.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.